Spinal cord stimulation may help selected patients with chronic nerve-related, spine-related, CRPS-related, pelvic, or complex pain when other treatments have not provided enough relief.
Spinal cord stimulation is an advanced treatment option for chronic pain when other therapies haven't provided lasting relief. Dr. Siefferman explains how spinal cord stimulators work, what to expect during the trial process, and how this therapy can help manage persistent pain.
Our team organizes conditions and treatments into related zones of expertise to make it easier to explore the care paths most relevant to your symptoms and goals.
Use the zone tags above to browse dedicated pages for each focus area, including services, providers, and what to expect during treatment.
Spinal cord stimulation is neuromodulation applied to the spine. Neuromodulation means we use electricity via electrodes to modulate how the nerves function. Spinal cord stimulation includes dorsal column stimulation, where we place the electrodes along the spine, and dorsal root ganglion stimulation, where we actually exit the electrode out of the spine along the nerve to catch the dorsal root ganglion of those specific nerves that we want to cover.
We usually use this as a means of last resort, meaning we don’t want to implant a medical device in someone if there’s a more reasonable, approachable treatment with durable success for that patient. We use it when nothing else has worked and when they desperately need pain control.
Before implanting a device, we do a trial. The spinal cord stimulator trial stays in for 7 days where the rep works with the patient closely to fine-tune the programming to really answer the question, “Will this work for me?” And during that time, we really want to see 80% or more improvement in the pain to justify progressing to a permanent implant.
If the patient does need a permanent implant—if they do well with the trial—we work closely with the spine surgeon, where I will operate with the spine surgeon to place the leads exactly where they need to go and the spine surgeon will make sure that everything is done appropriately for the spine and that the battery is placed appropriately.
This is an ongoing relationship that we have with patients where we optimize their spinal cord stimulator. Sometimes there are shifts, sometimes new pains come up, and we will need to reprogram periodically. There’s a process that goes on even beyond the implantation where we optimize the use of the stimulator.
So if this is something you are considering, we’re happy to speak to you about it. There are a variety of different companies that produce them. There are different techniques for stimulation, and depending on what your needs are, there are multiple options. So we will talk through those.
Spinal cord stimulation is an advanced neuromodulation treatment that uses targeted electrical stimulation near the spinal cord to help change how pain signals are processed. It may be considered for selected patients with chronic nerve-related, spine-related, CRPS-related, pelvic, or complex pain when conservative care, medications, injections, surgery, or other treatments have not provided enough relief.
At Manhattan Pain Medicine, spinal cord stimulation NYC care begins with diagnosis-first evaluation. The goal is to determine whether pain is coming from spinal nerves, the spine, peripheral nerves, pelvic nerves, CRPS-related pathways, or central pain mechanisms before considering a spinal cord stimulator trial. Spinal cord stimulation is not a cure for chronic pain, and it is not appropriate for every patient. It is considered only when the pain pattern, prior treatment history, safety profile, and goals support a trial-based neuromodulation pathway.
MPM specialists evaluate whether spinal cord stimulation may be appropriate by reviewing the patient’s diagnosis, pain distribution, spine history, nerve symptoms, prior imaging, prior procedures, medication response, surgical history, physical therapy history, psychological readiness, functional goals, medical risks, and insurance requirements. Spinal cord stimulation may be considered for selected patients with chronic back and leg pain, sciatica, nerve-related pain, pain after spine surgery, CRPS, foot pain, pelvic pain overlap, pudendal neuralgia overlap, or complex chronic pain.
MPM also evaluates whether dorsal root ganglion stimulation, peripheral nerve stimulation, repeat injections, epidural lysis of adhesions, medication management, pain psychology, rehabilitation, or surgical referral may be more appropriate.
Patients often search for spinal cord stimulation in Manhattan when pain has persisted despite medication, physical therapy, injections, epidural procedures, nerve blocks, surgery, or other conservative care. Many are trying to understand whether a spinal cord stimulator could help chronic back and leg pain, sciatica, CRPS, neuropathic pain, foot pain, pelvic pain overlap, or complex chronic pain.
MPM approaches spinal cord stimulation as one advanced option within a broader neuromodulation pathway, not as a device-first solution. The most important step is identifying whether the pain pathway is appropriate for spinal cord stimulation or whether another approach, such as dorsal root ganglion stimulation or peripheral nerve stimulation, may better match the pain pattern. A temporary trial is typically used before permanent implantation to assess relief, function, comfort, and safety.
Spinal cord stimulation fits within MPM’s Pelvic Pain, Complex Chronic Pain, Headache, and Musculoskeletal issues expertise because chronic pain often involves overlapping spine, nerve, pelvic, musculoskeletal, and nervous system pathways.
A patient may have spine-related nerve pain, CRPS, chronic back and leg pain, foot pain, pelvic pain overlap, pudendal neuralgia overlap, or central pain features. MPM evaluates how spinal cord stimulation fits within the broader care plan, which may also include dorsal root ganglion stimulation, peripheral nerve stimulation, epidural injections, epidural lysis of adhesions, sympathetic blocks, peripheral nerve blocks, nerve hydrodissection, medication management, pain psychology, rehabilitation, or surgical coordination when appropriate.
Before a spinal cord stimulator trial, MPM reviews the diagnosis, pain pattern, prior treatments, imaging, medications, safety factors, psychological readiness, infection risk, insurance requirements, and treatment goals. Patients may need imaging review, medical clearance, psychological screening, medication review, and insurance authorization before proceeding.
During the trial, temporary leads are placed near the spinal cord pain pathway and connected to an external device. The patient tracks pain relief, function, sleep, activity tolerance, stimulation comfort, and side effects. If the trial provides meaningful benefit and is well tolerated, permanent implantation may be discussed. If the trial does not help, the temporary leads are removed and permanent implantation is usually not recommended.
I cannot say enough good things about Manhattan Pain Medicine. From the moment I walked in, I felt truly cared for and taken seriously. Dr. Nino Mikaberidze, Director of Rheumatology, is exceptional — knowledgeable, compassionate, and incredibly thorough. She takes the time to listen, explains every...
The best care I've received as a chronic pain patient. I traveled from out of state to visit Manhattan Pain Medicine because I could not find knowledgeable doctors in my hometown for my hypermobility, and Ehlers-Danlos syndrome symptoms and comorbidities. Let me tell you, it was worth every travel e...
I was injured in a bicycle accident over 8 years ago. I’ve suffered throughout the years since my accident with nothing seeming to work. PT, Yoga, lifestyle changes, NOTHNG! I finally made an appointment with Dr Kane and I’m feeling an improvement in my life. I no longer stay up all night in pain, a...
One of the best experiences, if not the best, I have ever had at the doctor’s office. From the front desk to the nurses to the PA assisting the doctor this was a great experience. Dr.Nino actually listened to me and came up with a game plan. Would recommend this practice to as many people as I could...
I have very unique & severe nerve pain from CRPS which has no known specific cure. Dr. Siefferman has a huge tool box, far greater than the other 23 Drs. I have seen. He saved me from jumping off a bridge and continues to help me with both treatments and advice. Dr. S. is in a different league!
After two years of searching and feeling lost and let down, I finally found real help at Manhattan Pain Medicine. With Dr. Siefferman, Adam Rosenberg, Dr. Mikaberidze, and the whole team, I feel heard, supported and understood. Every symptom is being considered and I’m finally getting answers with m...
Why is Dr Dr. Tayyaba Ahmed one of the top pevic Floor specialists - 1- She wants to know a full history of what led the patient to get to this point. 2 - She listens intensley to the patient 3- She does not rush you 4- Extremely skilled at giving pelvic floor injections 5- I thank my luck stars she...
The staff was friendly and helpful. Dr. Siefferman was thoughtful, listened, asked questions and proposed simple safe ways to come to further conclusions regarding my pain and discomfort. The office staff including Dr. Siefferman is responsive even after the initial in-person visit. Very pleased.
Dr. Siefferman is a brilliant provider. While my pain is still a work in progress, Dr Siefferman always gives me options and explains his reasoning behind things. He listens to my feedback and concerns. I never feel rushed; and am grateful he works to meet me where I am. I highly recommend him.
What a great find! They listen to me, I listen to them and the diagnosis is made and a plan developed to develop an approach to treat all of my chronic pain. I wish I could have discovered this type of treatment sooner. This doctor and group give me hope.
Spinal cord stimulation is a neuromodulation treatment that uses electrical stimulation near the spinal cord to help modulate pain signals. It may be considered for selected chronic pain patients when other nonsurgical treatments, injections, procedures, or surgery have not provided enough relief. At MPM, spinal cord stimulation is considered only after diagnosis-first evaluation and usually begins with a temporary trial.
A spinal cord stimulator delivers controlled electrical stimulation near spinal pain pathways. The goal is to change how pain signals are transmitted or perceived by the nervous system. It does not repair discs, reverse nerve injury, cure CRPS, or remove the original pain generator. MPM evaluates whether the pain pattern is appropriate for this type of stimulation before recommending a trial.
Spinal cord stimulation may be considered for selected chronic nerve-related, spine-related, CRPS-related, lower extremity, pelvic-overlap, or complex chronic pain patterns. It may be relevant for some patients with chronic back and leg pain, sciatica, pain after spine surgery, CRPS, neuropathic pain, foot pain, or central pain features. It is not appropriate for every pain condition.
Spinal cord stimulation may help selected patients with chronic back and leg pain when symptoms appear related to nerve pathways and less invasive treatments have not provided enough relief. MPM evaluates whether the pain is coming from spinal nerves, disc disease, stenosis, prior surgery, peripheral nerves, joints, muscles, or another pain generator before considering a stimulator trial.
Spinal cord stimulation may be considered for selected patients with persistent sciatica or radicular pain when symptoms have not improved enough with appropriate treatment. It is not the first step for most sciatica patients. MPM evaluates imaging, nerve symptoms, prior epidural response, medication response, surgical history, and alternative pain sources before considering SCS.
Spinal cord stimulation may be considered for selected patients with complex regional pain syndrome when pain remains severe or functionally limiting despite other treatments. Response varies, and SCS is not a cure for CRPS. MPM evaluates pain distribution, autonomic features, prior sympathetic block response, functional goals, and whether SCS or dorsal root ganglion stimulation may be more appropriate.
Spinal cord stimulation may be considered for selected pelvic pain overlap when symptoms appear to involve spinal or neuromodulatory pain pathways. Pelvic pain can also come from pudendal neuralgia, pelvic floor dysfunction, endometriosis, pelvic dystonia, peripheral nerve pain, orthopedic contributors, or central sensitization. MPM evaluates these contributors before considering SCS.
Spinal cord stimulation may be considered in selected cases when pudendal neuralgia overlaps with broader pelvic, spinal, or complex pain pathways. However, some patients may be better suited for peripheral nerve stimulation or dorsal root ganglion stimulation depending on the pain pattern. MPM reviews nerve mapping, prior block response, anatomy, and treatment history before recommending a pathway.
Spinal cord stimulation targets pain pathways near the spinal cord. Peripheral nerve stimulation targets a specific peripheral nerve that appears to be contributing to pain. The best choice depends on the location of pain, suspected nerve pathway, prior diagnostic block response, anatomy, and treatment goals. MPM compares these options before recommending a trial.
Spinal cord stimulation targets broader spinal pain pathways, while dorsal root ganglion stimulation targets specific dorsal root ganglion structures involved in sensory and pain signaling. DRG stimulation may be more relevant for selected focal or regional pain patterns. MPM determines which approach may fit best based on diagnosis, pain distribution, and prior treatment response.
A spinal cord stimulator trial is a temporary test period before permanent implantation. Temporary leads are placed near the target spinal pain pathway and connected to an external device. The patient tracks pain relief, function, sleep, activity tolerance, stimulation comfort, and side effects. The trial helps determine whether permanent implantation should be considered.
The length of a spinal cord stimulator trial can vary based on clinical and insurance requirements. During the trial period, the patient and MPM evaluate whether stimulation provides meaningful pain relief, improved function, and tolerable stimulation. The goal is to gather enough information to decide whether permanent implantation is appropriate.
If the trial provides meaningful improvement in pain or function and the stimulation is well tolerated, permanent implantation may be discussed. MPM reviews the trial response, patient goals, risks, insurance requirements, and long-term device responsibilities before moving forward. A successful trial does not guarantee permanent results, but it provides important decision-making information.
If the trial does not provide meaningful relief or is not tolerated, the temporary leads are removed and permanent implantation is usually not recommended. A failed trial does not mean the pain is not real. It may mean that the pain pathway is not appropriate for SCS or that another treatment, such as DRG stimulation, peripheral nerve stimulation, medication management, injections, surgery, or rehabilitation, may need to be considered.
Risks may include pain flare, infection, bleeding, lead migration, lead fracture, device malfunction, uncomfortable stimulation, loss of benefit, implant site pain, need for reprogramming, battery replacement, revision surgery, nerve irritation, dural puncture headache, rare neurologic injury, and incomplete relief. MPM reviews risks, alternatives, and long-term device considerations before treatment.
Spinal cord stimulation may not be appropriate when the pain generator is unclear, when less invasive treatment options have not been fully evaluated, when infection risk is high, when medical clearance is not adequate, when psychological readiness is not appropriate, or when symptoms are better explained by another condition requiring different care. MPM also screens for urgent symptoms before recommending an SCS pathway.
Before care begins, our team helps patients understand the practical side of treatment, including insurance verification, out-of-network benefits, cost-share estimates, self-pay options, and billing questions. We believe patients should have as much clarity as possible before moving forward.
If you are considering spinal cord stimulation in NYC for chronic nerve pain, back and leg pain, sciatica, CRPS, pelvic pain overlap, pudendal neuralgia overlap, foot pain, or complex chronic pain, MPM can help determine whether this treatment pathway may be appropriate. Your evaluation will consider your diagnosis, pain pathway, prior care, safety factors, treatment goals, and whether SCS, DRG stimulation, peripheral nerve stimulation, or another option may fit your care plan.
Spinal cord stimulation is an advanced neuromodulation treatment that uses targeted electrical stimulation near the spinal cord to help modulate pain signals. It may be considered for selected patients with chronic nerve-related, spine-related, CRPS-related, pelvic, or complex pain when other treatments have not provided enough relief.
At Manhattan Pain Medicine (MPM), spinal cord stimulation NYC care begins with diagnosis-first evaluation. The goal is to determine whether the pain pathway is appropriate for spinal cord stimulation before considering a temporary trial. SCS is not a cure for chronic pain, and it is not appropriate for every patient.
Spinal cord stimulation does not repair discs, reverse spinal stenosis, cure nerve injury, or eliminate every pain generator. Instead, it delivers electrical stimulation near spinal pain pathways to influence how pain signals are processed by the nervous system.
For selected patients, this may reduce pain intensity, improve function, support activity tolerance, or reduce reliance on certain medications as part of a broader care plan. Results vary, and the treatment is evaluated through a temporary trial before permanent implantation is considered.
Spinal cord stimulation may be considered for selected chronic pain patterns, including chronic back and leg pain, sciatica, radicular pain, pain after spine surgery, neuropathic pain, CRPS, foot pain, pelvic pain overlap, pudendal neuralgia overlap, and complex chronic pain.
The key question is not simply whether the patient has chronic pain. The key question is whether the pain pathway is appropriate for SCS. Pain may come from spinal nerves, peripheral nerves, pelvic nerves, musculoskeletal structures, inflammatory disease, central sensitization, or multiple overlapping contributors. MPM evaluates these possibilities before recommending a stimulator trial.
SCS may be considered when chronic back and leg pain appears related to nerve pathways and has not improved enough with less invasive care. This can include selected patients with persistent radicular pain, sciatica, prior spine surgery, or complex spine-related nerve pain.
MPM reviews imaging, physical exam findings, pain distribution, prior epidural injection response, medication history, surgical history, and functional goals. This helps determine whether SCS, repeat epidural injections, epidural lysis of adhesions, DRG stimulation, medication management, rehabilitation, or surgical referral may be more appropriate.
CRPS and complex chronic pain can involve nerve sensitivity, autonomic features, movement limitation, fear of flares, and functional decline. SCS may be considered for selected patients when symptoms remain severe despite appropriate care.
For some CRPS or focal regional pain patterns, dorsal root ganglion stimulation may also be considered. MPM evaluates the pain location, autonomic features, prior sympathetic block response, functional goals, and treatment history before determining which neuromodulation pathway may fit best.
Pelvic pain may involve the pudendal nerve, pelvic floor muscles, pelvic organs, spine, sacral nerve roots, dorsal root ganglia, peripheral nerves, or central pain pathways. SCS may be considered in selected pelvic pain overlap cases, but it is not automatically the best neuromodulation option.
Some patients may be better suited for peripheral nerve stimulation or dorsal root ganglion stimulation depending on the pain pattern. MPM evaluates pelvic nerve mapping, prior pudendal nerve block response, pelvic floor findings, spine findings, medication history, and prior pelvic pain treatment before considering SCS.
Spinal cord stimulation targets broader spinal pain pathways. Dorsal root ganglion stimulation targets specific sensory nerve structures and may be considered for more focused regional pain patterns. Peripheral nerve stimulation targets a specific peripheral nerve that appears to be involved in the pain pattern.
These treatments are not interchangeable. MPM compares them based on the patient’s diagnosis, pain distribution, prior diagnostic block response, anatomy, medical history, and goals. The goal is to match the stimulation approach to the pain pathway rather than choosing a device first.
A spinal cord stimulator trial is typically performed before permanent implantation. Temporary leads are placed near the target spinal pain pathway and connected to an external device. The patient then evaluates pain relief, function, sleep, activity tolerance, stimulation comfort, and side effects.
A successful trial usually means the patient experiences meaningful improvement in pain or function with tolerable stimulation and acceptable safety. The exact threshold for success depends on the patient’s condition, goals, functional limitations, and clinical context. If the trial is successful, permanent implantation may be discussed. If the trial does not help, the temporary leads are removed and permanent implantation is usually not recommended.
If the trial is successful, MPM reviews the next steps with the patient. This may include permanent implantation planning, insurance authorization, device education, programming expectations, activity restrictions, infection risk review, medication planning, and long-term follow-up.
Permanent implantation requires ongoing device management. Patients may need reprogramming, follow-up visits, battery management, and evaluation if symptoms change or the device stops helping.
Spinal cord stimulation may require imaging review, psychological screening, medical clearance, medication review, infection risk assessment, insurance authorization, and long-term device follow-up.
Risks may include pain flare, infection, bleeding, lead migration, lead fracture, device malfunction, uncomfortable stimulation, loss of benefit, implant site pain, need for reprogramming, battery replacement, revision surgery, nerve irritation, dural puncture headache, rare neurologic injury, incomplete relief, or no relief.
Patients should seek urgent evaluation for fever, wound drainage, spreading redness, severe swelling, new weakness, new numbness, bowel or bladder dysfunction, saddle anesthesia, severe headache after a procedure, chest pain, shortness of breath, severe allergic reaction, rapidly worsening pain, device-related burning or shocking sensation, or new neurological symptoms.
For selected patients, spinal cord stimulation may be an important part of an advanced chronic pain plan. MPM’s role is to determine whether the pain pathway is appropriate, whether the patient is ready for a trial, and how SCS fits within a coordinated, diagnosis-first care plan.
